Assembly Biosciences Inc expected to post a loss of 56 cents a share - Earnings Preview

Assembly Biosciences

01/11/2021 11:31

* Assembly Biosciences Inc  ASMB.OQ   ASMB.O  is expected
to show a fall in quarterly revenue when it reports results on
November 3 (estimated). 
​* Refinitiv's mean analyst estimate for Assembly Biosciences
Inc is for a loss of 56 cents per share. For the same quarter
last year, the company reported a loss of 9 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Assembly
Biosciences Inc is $10.5​, about 70% above​ its last closing
price of $3.15. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Jun. 30 2021  -0.65       -0.66      -0.55     Beat    16.2
 Mar. 31 2021  -0.78       -0.79      -0.69     Beat    12.2
 Dec. 31 2020  -0.90       -0.90      -0.96     Missed  -6.2​
 Sep. 30 2020  -0.73       -0.75      -0.09     Beat    88
 Jun.          0.24​       -0.03      0.19      Beat    733.3​
 30​ 2020​                                              
 Mar. 31 2020  -1.00       -0.98      -0.76     Beat    22.3​
 Dec. 31 2019  -0.98       -1.01      -0.99     Beat    1.7
 Sep. 30 2019  -0.91       -0.93      -0.96     Missed  -3.2
 This summary was machine generated November 1 at 11:31 GMT.  All
figures in US dollars unless otherwise stated